Sunstone Hotel Investors, Inc., a stable REIT offers preferred shares with 7%+ yields. Click for my look at SHO and see if ...

Palantir's DoD contracts, strong Q1 2025 growth, and competitive edge in AI-driven platforms make it a standout growth ...

Babcock & Wilcox Enterprises, Inc. is addressing debt and boosting orders amidst execution risks. Click for more on BW stock ...

Voyager struggles with a negative enterprise value, financial risks, and limited catalysts in a competitive Alzheimer's ...

Blue Owl Capital Corporation outperforms with a 2% Q1 NAV return, solid portfolio quality, low non-accruals & first-lien ...

Explore REGENXBIO's RGX-121 gene therapy for Hunter syndrome, with an FDA decision due Nov 9, 2025. Click here to read my ...

The backlog for contract oil driller Valaris remains strong. Read why recent share buybacks signal management’s confidence ...

Pure Cycle has evolved from a water utility to a land developer, leveraging valuable water assets and the Sky Ranch ...

Kestra Medical Technologies, Ltd. sees sales growth but struggles with losses and slowing revenue. Click for risks tied to ...

Discover 2 reliable dividend growers with remarkable growth potential. Boost your cash flow passively by focusing on ...

AnaptysBio, Inc.'s rosnilimab shows promise in RA & ulcerative colitis, targeting $20B+ markets. Phase 2b results highlight ...

Urbana Corporation is family controlled, which explains some NAV discount, and private markets are not very liquid, but it's ...